Section Leader — Parenteral Development (EU)

Roche; Basel; Vor Ort; CHF 120.000 - 160.000; Vollzeit

Benefits dieser Stelle

80% working schedule

Zusammenfassung

Roche in Basel invites a Section Leader in Pharmaceutical Development EU to lead a team of about 8 scientists, directing parenteral formulation development from preclinical to launch and ongoing product support. You will drive lean processes, oversee regulatory filings from IMPD to BLA, shape global technical strategy, and collaborate across Roche sites to deliver innovative therapies.

A Ph.D. with 8+ years in biopharma and 5+ years of people management, plus fluent English, are required; 80%

Qualifikationen

• PhD in a scientific or engineering discipline with extensive biopharmaceutical experience (8+ years).
• Proven ability to lead and develop scientific teams and manage complex programs.
• Excellent communication and collaboration across global teams and senior leadership.

Aufgaben

• Lead a team of ~8 scientists, coaching and developing a high-performing environment.
• Provide strategic oversight for parenteral formulation development from preclinical to launch and support.
• Manage regulatory strategy and filings from IMPD to BLA and PAS.
• Shape global technical strategy and serve as a functional representative in global stakeholder interactions.
• Champion Lean principles and drive continuous improvement in operations.

Kenntnisse

People leadership

English proficiency

Strategic thinking

Cross-functional collaboration

Ausbildung

PhD in relevant field

Jobbeschreibung

Roche in Basel invites a Section Leader in Pharmaceutical Development EU to lead a team of about 8 scientists, directing parenteral formulation development from preclinical to launch and ongoing product support. You will drive lean processes, oversee regulatory filings from IMPD to BLA, shape global technical strategy, and collaborate across Roche sites to deliver innovative therapies.

A Ph.D. with 8+ years in biopharma and 5+ years of people management, plus fluent English, are required; 80%